Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Minority Interest (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Minority Interest for 12 consecutive years, with -$357000.0 as the latest value for Q2 2025.

  • Quarterly Minority Interest changed N/A to -$357000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$357000.0 through Jun 2025, changed N/A year-over-year, with the annual reading at $2.1 million for FY2024, 65.72% down from the prior year.
  • Minority Interest hit -$357000.0 in Q2 2025 for vTv Therapeutics, down from $977000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $62.6 million in Q1 2021 to a low of -$357000.0 in Q2 2025.
  • Historically, Minority Interest has averaged $19.4 million across 5 years, with a median of $15.9 million in 2022.
  • Biggest five-year swings in Minority Interest: skyrocketed 36.42% in 2023 and later tumbled 81.18% in 2025.
  • Year by year, Minority Interest stood at $25.0 million in 2021, then tumbled by 33.58% to $16.6 million in 2022, then plummeted by 63.02% to $6.1 million in 2023, then crashed by 65.72% to $2.1 million in 2024, then crashed by 116.98% to -$357000.0 in 2025.
  • Business Quant data shows Minority Interest for VTVT at -$357000.0 in Q2 2025, $977000.0 in Q1 2025, and $2.1 million in Q4 2024.